Ono Pharmaceutical has entered into a drug discovery partnership with U.S. AI drug discovery company Aitia in the neuroscience field. Under the partnership, the companies will jointly search for drug candidates against therapeutic targets identified by Aitia.
Ono Pharmaceutical announced on the 2nd that it had entered into a drug discovery partnership agreement with U.S. AI drug discovery company Aitia in the neuroscience field. The purpose of the partnership is to jointly advance drug discovery targeting therapeutic targets in the neuroscience field.
Under the partnership, Ono Pharmaceutical is reportedly planning to search for drug candidates against therapeutic targets identified by Aitia.
This article is limited to reporting the fact of the partnership and the specific results disclosed, and the information provided in the article is the basis for assessing future developments.